par D:A:D Study Group, Caroline;Sabin, Signe Westring;Worm, Rainer;Weber, Peter;Reiss, Wafaa;El-Sadr, François;Dabis, Stéphane ;De Wit, Mathew M.G.;Law, Antonella;d'Arminio Monforte, Nina;Friis-Møller, Ole;Kirk, Christian;Pradier, Ian;Weller, Andrew N.;Phillips, Jens D;Lundgren,
Référence Lancet, 371, 9622, page (1417-1426)
Publication Publié, 2008-04
Référence Lancet, 371, 9622, page (1417-1426)
Publication Publié, 2008-04
Article révisé par les pairs
Résumé : | Whether nucleoside reverse transcriptase inhibitors increase the risk of myocardial infarction in HIV-infected individuals is unclear. Our aim was to explore whether exposure to such drugs was associated with an excess risk of myocardial infarction in a large, prospective observational cohort of HIV-infected patients. |